By Jake Sherman Not too long ago, talking in public about the differences between psilocybin and LSD would probably draw some odd looks from people. America’s “War on Drugs” had a strong cultural impact around the world...
The Latest
How Psychedelics Can Treat Depression
By Brian Lissak For a thorough, in-depth treatment of psychedelics, their history, and their current research and medicinal uses, check out PsyTech’s comprehensive course on the fundamentals of psychedelic medicine. As...
7 Things You Need to Know About Psychedelic Medicine
By Tessa Eskin For a thorough, in-depth treatment of psychedelics, their history, and their current research and medicinal uses, check out PsyTech’s comprehensive course on the fundamentals of psychedelic medicine...
What is Ketamine, and How Does it Treat Depression?
By Tessa Eskin One of the most challenging side effects of modernity – only magnified during these troubled times – is the alarming growth of depression cases. As of January 2020, over 264 million people...
Novamind CEO Shares His Thoughts on Psychedelics, Policy, and Healing
Yaron Conforti is a veteran entrepreneur and investor in venture-stage companies, with a longstanding interest in psychedelics. He is the Co-founder, Chief Executive Officer, and Director of Novamind, which focuses...
How Can Industry Leaders Help Advance Psychedelics Policy Forward?
By Risha Groner On October 27, 1970, President Richard Nixon signed into law the Controlled Substances Act. Some of these substances had already spawned many studies into their potential healing properties. But...
